Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock

• Status: Completed
• Trial end date: 2020-06-28
• Target enrollment: 0
• Participant gender: All

Summary

This open-label, randomized controlled trial aimed to investigate the effect of a fixed dose of terlipressin added to usual care vs. usual care alone on renal perfusion in patients with septic shock.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Southeast University, China
• Treatments: Terlipressin

Criteria

Inclusion Criteria:

1. Adult septic shock patients (age≥18 years old)

2. Norepinephrine dose was more than or equal to 15μg/min

Exclusion Criteria:

1. Age older than 85 years

2. Serum creatinine more than 177 μmol/L

3. Acute myocardial ischemia

4. Acute mesenteric artery ischemia

5. Pregnancy

6. Expected death within 24 hours.